U.S. Markets closed

SIGA Technologies, Inc. (SIGA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.05-0.05 (-1.61%)
At close: 3:50PM EDT
People also watch
PIPSCLNVICLSPPIPTIE
Full screen
Previous Close3.10
Open3.10
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.05 - 3.10
52 Week Range1.90 - 3.88
Volume19,227
Avg. Volume33,936
Market Cap240.28M
Beta0.85
PE Ratio (TTM)-5.10
EPS (TTM)-0.6
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Trade prices are not sourced from all markets
  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube2 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • GlobeNewswire3 months ago

    SIGA to Present at the Jefferies Global Healthcare Conference on June 9, 2017

    NEW YORK, May 31, 2017-- SIGA Technologies, Inc., a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that Dr. Phillip ...

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube5 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)